Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors and Hematologic Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03512340
What this trial is testing

Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers

Who this might be right for
Advanced Solid CancersHematologic Cancers
Surface Oncology 148
Early research (Phase 1)Study completedNCT00840190
What this trial is testing

Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies

Who this might be right for
Solid TumorHematologic Malignancy
Piramal Enterprises Limited 29
Early research (Phase 1)Study completedNCT00659568
What this trial is testing

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

Who this might be right for
Breast CancerEndometrial CancerKidney Cancer+3 more
London Health Sciences Centre 28
Early research (Phase 1)Ended earlyNCT06188208
What this trial is testing

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Hematologic Tumors
Vividion Therapeutics, Inc. 132
Early research (Phase 1)Study completedNCT00054483
What this trial is testing

Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+31 more
National Cancer Institute (NCI) 69
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT01393509
What this trial is testing

The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies

Who this might be right for
Metastatic Solid TumorLymphomaMyeloproliferative Neoplasms (MPN)
Memorial Sloan Kettering Cancer Center 47
Early research (Phase 1)Ended earlyNCT00354185
What this trial is testing

PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+57 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00004189
What this trial is testing

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00049712
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Ended earlyNCT02711137
What this trial is testing

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors
Incyte Corporation 137
Testing effectiveness (Phase 2)Study completedNCT02873975
What this trial is testing

LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency

Who this might be right for
Advanced Cancers
Dana-Farber Cancer Institute 27
Early research (Phase 1)UnknownNCT00710697
What this trial is testing

Cardiac Safety Assessment Study of Picoplatin in Solid Tumors

Who this might be right for
Solid Tumors
Poniard Pharmaceuticals 40
Early research (Phase 1)Study completedNCT01723020
What this trial is testing

Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsCancer+5 more
Kartos Therapeutics, Inc. 107
Early research (Phase 1)Study completedNCT02492789
What this trial is testing

A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients

Who this might be right for
Solid Tumors and Hematologic Malignancy
Atridia Pty Ltd. 49
Early research (Phase 1)Ended earlyNCT00915278
What this trial is testing

A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors

Who this might be right for
Advanced Non-Hematologic Malignancies
Pfizer 33
Not applicableTemporarily pausedNCT05091632
What this trial is testing

Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT03386526
What this trial is testing

APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies

Who this might be right for
Advanced Solid Tumors or Hematologic Malignancies
Ascentage Pharma Group Inc. 90
Early research (Phase 1)WithdrawnNCT00820768
What this trial is testing

A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Who this might be right for
Solid Tumor
Celgene
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Next Page